Showing results (1741-1750 of 3,024) with videos related to
Sort By:
Pageof 303
Current Pharmaceutical Biotechnology|September 24, 2016
Astaxanthin; a Promising Protector Against Gentamicin-Induced Nephrotoxicity in RatsYasser O Mosaad, Naglaa Abd El Khalik Gobba, Mohammed A HusseinCurrent Pharmaceutical Biotechnology|May 10, 2017
Water-in-Oil Microemulsions for Protein Delivery: Loading Optimization and StabilityDiego R Perinelli, Marco Cespi, Stefania Pucciarelli, et al.Current Pharmaceutical Biotechnology|July 8, 2017
Anti-oxidative and Anti-microbial Activities of Purified MPN-1-1 from Persicaria nepalensis (Meisn.) MiyabeWoong-Suk Yang, Seung-Hoon Yang, Jae-Yong Lee, et al.Current Pharmaceutical Biotechnology|September 3, 2016
Opposite Effects of Two-Derived Antioxidants from Physalis pubescens L. on Hepatocellular Carcinoma Cell Line MalhavuJing-Jing Wang, Yang Yu, Bai-Qing Zhang, et al.Current Pharmaceutical Biotechnology|August 25, 2016
New Directions for Half-Life Extension of Protein Therapeutics: The Rise of Antibody Fc Domains and FragmentsLili Wang, Tianlei YingCurrent Pharmaceutical Biotechnology|September 9, 2016
Cell Proliferation and Cytotoxicity AssaysAysun Adan, Yağmur Kiraz, Yusuf BaranCurrent Pharmaceutical Biotechnology|April 19, 2018
Circulating miR-10a as Predictor of Therapy Response in Rheumatoid Arthritis Patients Treated with MethotrexateHonghai Hong, Haihui Yang, Yong XiaCurrent Pharmaceutical Biotechnology|December 17, 2008
Monoclonal antibodies--regulatory challengesChristian K SchneiderCurrent Pharmaceutical Biotechnology|December 17, 2008
Development and production of commercial therapeutic monoclonal antibodies in Mammalian cell expression systems: an overview of the current upstream technologiesMichel Chartrain, Lily ChuCurrent Pharmaceutical Biotechnology|December 17, 2008
Heterogeneity of monoclonal antibodies revealed by charge-sensitive methodsJ Vlasak, R IonescuPageof 303